Protara Therapeutics, Inc.

US$2.30As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TARAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (32.37%)
Div yield —
ROE (57.40%)
Biotechnology
Beta (5Y) 1.54
PE TTM —
TSR TTM (55.60%)
Mkt cap US$135.9M
ROIC (38.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.43
5.45%
(83.09%)
Hold 3|9|9|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.07
0.06
0.06
14.65%
23.28%
12.26%
6.35%
Revenue$M
6.695
6.596
6.593
6.901
4.42%
5.13%
4.14%
5.79%
Peers (US$135.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.395
(0.082)
(0.068)
EBIT/Intx
11.24
0.572
0.532
Own earn%
(193.58)
(21.76)
(23.93)
Sh yield%
54.63
28.40
29.06
Owners
Insiders/Inst%
13.26
79.70
Short interest%
2.46
SBC / revenue%
4.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
6